<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0034-7531</journal-id>
<journal-title><![CDATA[Revista Cubana de Pediatría]]></journal-title>
<abbrev-journal-title><![CDATA[Rev Cubana Pediatr]]></abbrev-journal-title>
<issn>0034-7531</issn>
<publisher>
<publisher-name><![CDATA[Centro Nacional de Información de Ciencias MédicasEditorial Ciencias Médicas]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0034-75312020000300014</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Efectividad de la terapia física intensiva en enfermedades huérfanas]]></article-title>
<article-title xml:lang="en"><![CDATA[Effectivenes of intensive physical therapy in orphan diseases]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Mozo Pérez]]></surname>
<given-names><![CDATA[Ana Liliana]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Beltrán De La Rosa]]></surname>
<given-names><![CDATA[Elisama Esther]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Mateus de Oro]]></surname>
<given-names><![CDATA[Cirit Del Carmen]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Parody Muñoz]]></surname>
<given-names><![CDATA[Alexander]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Avendaño Escorcia]]></surname>
<given-names><![CDATA[Carmen Lucia]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad Metropolitana Grupo de investigación CEPUM ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Colombia</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Centro Neurológico Integral de Santander (NISA)  ]]></institution>
<addr-line><![CDATA[ ]]></addr-line>
<country>Colombia</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>09</month>
<year>2020</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>09</month>
<year>2020</year>
</pub-date>
<volume>92</volume>
<numero>3</numero>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_arttext&amp;pid=S0034-75312020000300014&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_abstract&amp;pid=S0034-75312020000300014&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.sld.cu/scielo.php?script=sci_pdf&amp;pid=S0034-75312020000300014&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[RESUMEN  Introducción: La terapia física intensiva en enfermedades huérfanas, es un método para el tratamiento a pacientes con diferentes trastornos neurológicos, especialmente en la disfunción neuromuscular y musculo esquelética, como secuelas de las crisis metabólicas padecidas por una enfermedad neurodegenerativa que se caracteriza porque los afectados presentan un olor particular en la orina, semejante al jarabe de arce usado como alimento.  Objetivo:  Describir los resultados obtenidos a través de la aplicación de la terapia física intensiva en enfermedades huérfanas en un paciente.  Presentación del caso: Niño de 9 años, con secuelas secundarias a la enfermedad neurodegenerativa citada. La evaluación inicial se realizó a través del índice de función motora GMFM 88-66, aplicado antes y después de cada intervención. El tratamiento consistió en el desarrollo del programa basado en la terapia física intensiva, en cuatro sesiones, durante cuatro semanas, cuatro horas por día, sin interrupción, con un total de 80 horas por cada intervención.  Conclusiones: La terapia física intensiva en enfermedades huérfanas, proporciona cambios significativos en comparación con la fisioterapia tradicional. Combina varias técnicas fundamentadas en la base fisiológica del ejercicio, aumenta la posibilidad de mejoras en las secuelas a nivel motor en el caso de enfermedad neurodegenerativa y mejora la función motora gruesa en el niño. En general, se aprecian cambios en la evolución del paciente e impacto en el sistema musculo esquelético, disfunción neuromuscular y mejoría en su calidad de vida y clínica. Puede ser aplicable en otros niños con alteraciones motoras secundarias a enfermedades huérfanas o raras.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[ABSTRACT  Introduction:  Intensive physical therapy in orphan diseases is a method for the treatment of patients with different neurological disorders, especially neuromuscular and skeletal muscle dysfunction as a consequence of metabolic crisis suffered due to a neurodegenerative disease which has as a characteristic that the patients present a particular smell in the urine, similar to the maple syrup used as food.  Objective:  To describe the results obtained through the use of intensive physical therapy in patients with orphan diseases.  Case presentation:  Nine years old boy with secondary sequelae of the above mentioned neurodegenerative disease. The initial evaluation was made with the index of motor function called GMFM 88-66 used before and after each intervention. The treatment involves the development of a program based in the intensive physical therapy in 4 sessions during 4 weeks and 4 hours each day, without stops and with a total of 80 hours per each intervention.  Conclusions:  Intensive physical therapy in orphan diseases provides significant changes in comparison with the traditional physiotherapy. It combines different techniques focused in the physiologic base of the exercises; in the case of neurodegenerative diseases, it increased the chances of improvement in the sequelaes of the motor level, and it improved the gross motor function in the boy. In general terms, there is evidence of changes in the evolution of the patient and impact in the skeletal muscle system, in the neuromuscular dysfunction and improvement in the clinical and life quality. This technique can be used in other children with motor disruptions secondary to orphan or rare diseases.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[disfunción neuromuscular]]></kwd>
<kwd lng="es"><![CDATA[terapia física intensiva en enfermedades huérfanas]]></kwd>
<kwd lng="es"><![CDATA[calidad de vida]]></kwd>
<kwd lng="es"><![CDATA[función cognitiva]]></kwd>
<kwd lng="en"><![CDATA[Neuromuscular dysfunction]]></kwd>
<kwd lng="en"><![CDATA[intensive physical therapy in orphan diseases]]></kwd>
<kwd lng="en"><![CDATA[life quality]]></kwd>
<kwd lng="en"><![CDATA[cognitive function]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Alagesan]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Shetty]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Effect of modified suit therapy in spastic diplegic cerebral palsy-a single blinded randomized controlled trial]]></article-title>
<source><![CDATA[J Health Allied Sci]]></source>
<year>2011</year>
<volume>9</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>14</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Oliveira]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<source><![CDATA[Curso teórico y práctico básico]]></source>
<year>2019</year>
<publisher-loc><![CDATA[Florida, EE. UU ]]></publisher-loc>
<publisher-name><![CDATA[Protocolo Pediasuit]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Anaya]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<source><![CDATA[PEDIASUIT para niños con diversas patologías. 2015]]></source>
<year>2015</year>
<publisher-name><![CDATA[Diario Los Tiempos]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Karada&#287;]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Giray]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[The clinical aspects and effectiveness of suit therapies for cerebral palsy: A systematic review]]></article-title>
<source><![CDATA[Turkish J Physic Med Rehabilitat]]></source>
<year>2019</year>
<volume>5</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>93-110</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Park]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Lee]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Nam]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Park]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Efficacy of intensive neuro developmental treatment for children with developmental delay, with or without cerebral palsy]]></article-title>
<source><![CDATA[Ann Rehabilitat Med]]></source>
<year>2017</year>
<volume>41</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>90-6</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Strauss]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Carson]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Soltys]]></surname>
<given-names><![CDATA[K]]></given-names>
</name>
<name>
<surname><![CDATA[Young]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Bowser]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Branched-chain &#945;-ketoacid dehydrogenase deficiency (maple syrup urine disease): Treatment, biomarkers, and outcomes]]></article-title>
<source><![CDATA[Mol Genet Metabol]]></source>
<year>2020</year>
<volume>129</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>193-206</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Marchantt]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Lippi]]></surname>
<given-names><![CDATA[Q]]></given-names>
</name>
<name>
<surname><![CDATA[Villanueva]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Selamé]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Puchi]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Enfermedad de orina con olor a jarabe de arce: reporte de dos casos]]></article-title>
<source><![CDATA[Rev ANACEM]]></source>
<year>2016</year>
<volume>10</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>30-4</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Abiri]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Saei]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Eghbali]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Karamzadeh]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Shirzadeh]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Sharifi]]></surname>
<given-names><![CDATA[Z]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Maple syrup urine disease mutation spectrum in a cohort of 40 consanguineous patients and insilico analysis of novel mutations]]></article-title>
<source><![CDATA[Metabolic Brain Dis]]></source>
<year>2019</year>
<volume>34</volume>
<numero>4</numero>
<issue>4</issue>
<page-range>1-12</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Menkes]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Hurst]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Craig]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[A new syndrome: progressive familial infantile cerebral dysfunction associated with an unusual urinary substance]]></article-title>
<source><![CDATA[Pediatrics J]]></source>
<year>1954</year>
<volume>14</volume>
<numero>5</numero>
<issue>5</issue>
<page-range>462</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lanza]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Montalvan]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Enfermedad de la orina de jarabe de arce: trastornos metabólicos y limitaciones en honduras]]></article-title>
<source><![CDATA[Rev Méd Honduras]]></source>
<year>2017</year>
<volume>85</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>35-9</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Meneses]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<source><![CDATA[Protocolo de manejo nutricional para niños con enfermedad de orina con olor a jarabe de arce y fenilcetonuria en el Hospital Universitario San Ignacio]]></source>
<year>2015</year>
<publisher-loc><![CDATA[Bogotá, Colombia ]]></publisher-loc>
<publisher-name><![CDATA[Pontificia Universidad Javeriana]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Vallejo]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Valencia]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<source><![CDATA[Estudio técnico de métodos TheraSuit, PediaSuit, PenguinSuit y Adelitsuit para pacientes con parálisis cerebral en el marco del procedimiento técnico científico y participativo de exclusiones. Reporte N° 10]]></source>
<year>2018</year>
<publisher-loc><![CDATA[Colombia ]]></publisher-loc>
<publisher-name><![CDATA[Universidad Nacional, Instituto de Evaluación Tecnológica en Salud]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wilbarger]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Wilbarger]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Wilbarger approach to treating sensory defensiveness and clinical application of the sensory diet. Sections in alternative and complementary programs for intervention]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Bundy]]></surname>
<given-names><![CDATA[AC]]></given-names>
</name>
<name>
<surname><![CDATA[Murray]]></surname>
<given-names><![CDATA[EA]]></given-names>
</name>
<name>
<surname><![CDATA[Lane]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<source><![CDATA[Sensory integration: Theory and Practice]]></source>
<year>2002</year>
<edition>2nd</edition>
<publisher-loc><![CDATA[Philadelphia ]]></publisher-loc>
<publisher-name><![CDATA[F.A. Davis]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Marek]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
<name>
<surname><![CDATA[Cramer]]></surname>
<given-names><![CDATA[JT]]></given-names>
</name>
<name>
<surname><![CDATA[Fincher]]></surname>
<given-names><![CDATA[AL]]></given-names>
</name>
<name>
<surname><![CDATA[Massey]]></surname>
<given-names><![CDATA[LL]]></given-names>
</name>
<name>
<surname><![CDATA[Dangelmaier]]></surname>
<given-names><![CDATA[SM]]></given-names>
</name>
<name>
<surname><![CDATA[Purkayastha]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Acute effects of static and propioceptive neuromuscular facilitation stretching on muscle stregth and power output]]></article-title>
<source><![CDATA[J Athl Train]]></source>
<year>2005</year>
<volume>40</volume>
<numero>2</numero>
<issue>2</issue>
<page-range>94-103</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Duchateau]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Semmier]]></surname>
<given-names><![CDATA[JG]]></given-names>
</name>
<name>
<surname><![CDATA[Enoka]]></surname>
<given-names><![CDATA[RM]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Training adaptations in the behavior of human motor units]]></article-title>
<source><![CDATA[J Appl Physiol]]></source>
<year>2006</year>
<volume>101</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>1766-75</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Budtinger]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
<name>
<surname><![CDATA[Bombarda]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Método Pediasuit &#8482; en el tratamiento de la parálisis cerebral: informes de casos]]></article-title>
<source><![CDATA[Fis Senectus Uno Chapecó]]></source>
<year>2018</year>
<volume>6</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>4-12</page-range></nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Licona]]></surname>
<given-names><![CDATA[T]]></given-names>
</name>
<name>
<surname><![CDATA[Banegas]]></surname>
<given-names><![CDATA[L]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Enfermedad de Orina Olor a Jarabe de Arce: presentación de caso clínico]]></article-title>
<source><![CDATA[Acta Pediátr Hondureña]]></source>
<year>2015</year>
<volume>6</volume>
<numero>1</numero>
<issue>1</issue>
<page-range>423-9</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Zeltner]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Baumgartne]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Bondarenko]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Ensenauer]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[Karall]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Kölker]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Development and psychometric evaluation of the MetabQoL 1.0: a quality of life questionnaire for Paediatric patients with intoxication-type inborn errors of metabolism]]></article-title>
<source><![CDATA[Informes JIMD]]></source>
<year>2017</year>
<volume>37</volume>
<page-range>27-35</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
